1. Home
  2. ACHL vs XPL Comparison

ACHL vs XPL Comparison

Compare ACHL & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHL
  • XPL
  • Stock Information
  • Founded
  • ACHL 2016
  • XPL 1984
  • Country
  • ACHL United Kingdom
  • XPL United States
  • Employees
  • ACHL N/A
  • XPL N/A
  • Industry
  • ACHL Biotechnology: Biological Products (No Diagnostic Substances)
  • XPL Precious Metals
  • Sector
  • ACHL Health Care
  • XPL Basic Materials
  • Exchange
  • ACHL Nasdaq
  • XPL Nasdaq
  • Market Cap
  • ACHL 46.8M
  • XPL 49.4M
  • IPO Year
  • ACHL 2021
  • XPL N/A
  • Fundamental
  • Price
  • ACHL $1.14
  • XPL $0.65
  • Analyst Decision
  • ACHL Buy
  • XPL Strong Buy
  • Analyst Count
  • ACHL 2
  • XPL 2
  • Target Price
  • ACHL $4.00
  • XPL $1.60
  • AVG Volume (30 Days)
  • ACHL 266.7K
  • XPL 43.4K
  • Earning Date
  • ACHL 11-14-2024
  • XPL 11-05-2024
  • Dividend Yield
  • ACHL N/A
  • XPL N/A
  • EPS Growth
  • ACHL N/A
  • XPL N/A
  • EPS
  • ACHL N/A
  • XPL N/A
  • Revenue
  • ACHL N/A
  • XPL N/A
  • Revenue This Year
  • ACHL N/A
  • XPL N/A
  • Revenue Next Year
  • ACHL N/A
  • XPL N/A
  • P/E Ratio
  • ACHL N/A
  • XPL N/A
  • Revenue Growth
  • ACHL N/A
  • XPL N/A
  • 52 Week Low
  • ACHL $0.63
  • XPL $0.43
  • 52 Week High
  • ACHL $1.76
  • XPL $0.98
  • Technical
  • Relative Strength Index (RSI)
  • ACHL 55.79
  • XPL 58.24
  • Support Level
  • ACHL $1.12
  • XPL $0.59
  • Resistance Level
  • ACHL $1.18
  • XPL $0.63
  • Average True Range (ATR)
  • ACHL 0.05
  • XPL 0.03
  • MACD
  • ACHL -0.00
  • XPL 0.01
  • Stochastic Oscillator
  • ACHL 33.33
  • XPL 78.00

About ACHL Achilles Therapeutics plc

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

About XPL Solitario Resources Corp.

Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.

Share on Social Networks: